{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:37:56Z","timestamp":1790948276294,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"am","delay-in-days":300,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AA028807"],"award-info":[{"award-number":["R01 AA028807"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AA013520"],"award-info":[{"award-number":["U01 AA013520"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U24 AA025479"],"award-info":[{"award-number":["U24 AA025479"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.neuropharm.2023.109508","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T21:36:08Z","timestamp":1679088968000},"page":"109508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Selective PDE4B and PDE4D inhibitors produce distinct behavioral responses to ethanol and GABAergic drugs in mice"],"prefix":"10.1016","volume":"231","author":[{"given":"Yuri A.","family":"Blednov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Mayfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5345-4431","authenticated-orcid":false,"given":"Robert O.","family":"Messing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2023.109508_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ab.2019.03.012","article-title":"Electrochemical studies of human nAChR a7 subunit phosphorylation by kinases PKA, PKC and Src","volume":"574","author":"Ahmad","year":"2019","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2023.109508_bib2","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1213\/ane.0b013e3181875a31","article-title":"A transmembrane residue influences the interaction of propofol with the strychnine-sensitive glycine alpha1 and alpha1beta receptor","volume":"107","author":"Ahrens","year":"2008","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2023.109508_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fnins.2014.00129","article-title":"Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL\/6J mice","volume":"8","author":"Blednov","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109508_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108220","article-title":"Apremilast regulates acute effects of ethanol and other GABAergic drugs via protein kinase A-dependent signaling","volume":"178","author":"Blednov","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109508_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109255","article-title":"Apremilast-induced increases in acute ethanol intoxication and decreases in ethanol drinking in mice involve PKA phosphorylation of GABAA beta3 subunits","volume":"220","author":"Blednov","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109508_bib6","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/acer.13615","article-title":"Apremilast alters behavioral responses to ethanol in mice: II. Increased sedation, intoxication, and reduced acute functional tolerance","volume":"42","author":"Blednov","year":"2018","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2023.109508_bib7","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/acer.13616","article-title":"Apremilast alters behavioral responses to ethanol in mice: I. Reduced consumption and preference","volume":"42","author":"Blednov","year":"2018","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2023.109508_bib8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fnmol.2018.00154","article-title":"PKA and PKC modulators affect ion channel function and internalization of recombinant Alpha1 and alpha1-beta Glycine receptors","volume":"11","author":"Breitinger","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109508_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/(SICI)1096-9861(19990503)407:2<287::AID-CNE9>3.0.CO;2-R","article-title":"Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect","volume":"407","author":"Cherry","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2023.109508_bib10","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S0022-3565(25)21291-5","article-title":"Genetic selection and characterization of mouse lines for acute functional tolerance to ethanol","volume":"279","author":"Erwin","year":"1996","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109508_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2014.10.002","article-title":"Anesthetics target interfacial transmembrane sites in nicotinic acetylcholine receptors","volume":"96","author":"Forman","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109508_bib12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cellsig.2013.12.003","article-title":"Structural basis for the design of selective phosphodiesterase 4B inhibitors","volume":"26","author":"Fox","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuropharm.2023.109508_bib13","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00213-014-3852-3","article-title":"Reduction of alcohol drinking of alcohol-preferring (P) and high-alcohol drinking (HAD1) rats by targeting phosphodiesterase-4 (PDE4)","volume":"232","author":"Franklin","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2023.109508_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159103","article-title":"Pre-clinical and clinical evidence for suppression of alcohol intake by apremilast","author":"Grigsby","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2023.109508_bib15","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1007\/s00213-014-3480-y","article-title":"Mice deficient in phosphodiesterase-4A display anxiogenic-like behavior","volume":"231","author":"Hansen","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2023.109508_bib16","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1021\/bi00316a032","article-title":"Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C","volume":"23","author":"Hidaka","year":"1984","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2023.109508_bib17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00213-011-2290-8","article-title":"Inhibition of phosphodiesterase-4 decreases ethanol intake in mice","volume":"218","author":"Hu","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2023.109508_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115443","article-title":"Selective inhibition of PDE4B reduces binge drinking in two C57BL\/6 substrains","volume":"22","author":"Jimenez Chavez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109508_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2012.07.050","article-title":"Comparison of cAMP-specific phosphodiesterase mRNAs distribution in mouse and rat brain","volume":"525","author":"Johansson","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2023.109508_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ph9010008","article-title":"Propofol and AZD3043 inhibit adult muscle and neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes","volume":"9","author":"Jonsson Fagerlund","year":"2016","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuropharm.2023.109508_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuropharm.2010.05.004","article-title":"Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues","volume":"59","author":"Lakics","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109508_bib22","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1007\/s00213-017-4631-8","article-title":"The phosphodiesterase-4 inhibitor roflumilast decreases ethanol consumption in C57BL\/6J mice","volume":"234","author":"Liu","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2023.109508_bib23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1530-0277.2010.01383.x","article-title":"Intermittent (every-other-day) drinking induces rapid escalation of ethanol intake and preference in adolescent and adult C57BL\/6J mice","volume":"35","author":"Melendez","year":"2011","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2023.109508_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/proteomes6040042","article-title":"Evaluation of the phosphoproteome of mouse alpha 4\/beta 2-containing nicotinic acetylcholine receptors in vitro and in vivo","volume":"6","author":"Miller","year":"2018","journal-title":"Proteomes"},{"key":"10.1016\/j.neuropharm.2023.109508_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1126\/science.1323140","article-title":"Functional modulation of GABAA receptors by cAMP-dependent protein phosphorylation","volume":"257","author":"Moss","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2023.109508_bib26","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s11515-016-1424-0","article-title":"Phosphodiesterase 4 inhibitors and drugs of abuse: current knowledge and therapeutic opportunities","volume":"11","author":"Olsen","year":"2016","journal-title":"Front. Biol."},{"key":"10.1016\/j.neuropharm.2023.109508_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0891-0618(00)00097-1","article-title":"Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography. Comparison with monkey and rat brain","volume":"20","author":"Perez-Torres","year":"2000","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2023.109508_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.physbeh.2004.10.007","article-title":"Evaluation of a simple model of ethanol drinking to intoxication in C57BL\/6J mice","volume":"84","author":"Rhodes","year":"2005","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2023.109508_bib29","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1517\/14728222.2013.818656","article-title":"PDE4 as a target for cognition enhancement","volume":"17","author":"Richter","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.neuropharm.2023.109508_bib30","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1369-1600.2012.00481.x","article-title":"Escalation of intake under intermittent ethanol access in diverse mouse genotypes","volume":"18","author":"Rosenwasser","year":"2013","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2023.109508_bib31","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cellsig.2014.05.014","article-title":"Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity","volume":"26","author":"Schafer","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuropharm.2023.109508_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102449","article-title":"Efficacy of selective PDE4D negative allosteric modulators in the object retrieval task in female cynomolgus monkeys (Macaca fascicularis)","volume":"9","author":"Sutcliffe","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2023.109508_bib33","doi-asserted-by":"crossref","first-page":"14805","DOI":"10.1073\/pnas.1514657112","article-title":"Compromising the phosphodependent regulation of the GABAAR beta3 subunit reproduces the core phenotypes of autism spectrum disorders","volume":"112","author":"Vien","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2023.109508_bib34","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s00213-018-4895-7","article-title":"Cyclic nucleotide phosphodiesterases: potential therapeutic targets for alcohol use disorder","volume":"235","author":"Wen","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2023.109508_bib35","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1111\/j.1530-0277.2012.01845.x","article-title":"The phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring Fawn-Hooded rats","volume":"36","author":"Wen","year":"2012","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2023.109508_bib36","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1523\/JNEUROSCI.4997-08.2009","article-title":"The involvement of hypothalamic sleep pathways in general anesthesia: testing the hypothesis using the GABAA receptor beta3N265M knock-in mouse","volume":"29","author":"Zecharia","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109508_bib37","first-page":"587","article-title":"Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme","volume":"27","author":"Zhang","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109508_bib38","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/sj.npp.1301537","article-title":"Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B)","volume":"33","author":"Zhang","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109508_bib39","doi-asserted-by":"crossref","first-page":"8538","DOI":"10.1021\/acs.jmedchem.7b01050","article-title":"The discovery of a novel phosphodiesterase (PDE) 4B-preferring radioligand for positron emission tomography (PET) imaging","volume":"60","author":"Zhang","year":"2017","journal-title":"J. Med. Chem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823000989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823000989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:38:02Z","timestamp":1777426682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390823000989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":39,"alternative-id":["S0028390823000989"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109508","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective PDE4B and PDE4D inhibitors produce distinct behavioral responses to ethanol and GABAergic drugs in mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109508"}}